Review Article
GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes
| GLP 1 RAs | Brand name | Administration | Action |
| Exenatide | Byetta® | Twice daily | Short acting | Exenatide-LAR | Bydureon® | Once weekly | Long acting | Lixisenatide | Lyxumia® | Once daily | Short acting | Liraglutide | Victoza® | Once daily | Long acting | Albiglutide | Eperzan® | Once weekly | Long acting | Dulaglutide | Trulicity® | Once weekly | Long acting |
|
|